Publications by authors named "Peter F Bross"

Claim this Profile
R
Regulation of biologic oncology products in the FDA׳s Center for Biologics Evaluation and Research.
Peter F Bross, Chaohong Fan, Bindu George, Kevin Shannon, Bharat H Joshi

Urol Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluation.
Ramjay S Vatsan, Peter F Bross, Ke Liu, Marc Theoret, Angelo R De Claro

J Immunother Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approval summary for bortezomib for injection in the treatment of multiple myeloma.
Peter F Bross, Robert Kane, Ann T Farrell, Sophia Abraham, Kimberly Benson

Clin Cancer Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.
Robert C Kane, Peter F Bross, Ann T Farrell, Richard Pazdur

Oncologist· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant in postmenopausal women with advanced breast cancer.
Peter F Bross, Amy Baird, Gang Chen, Josephine M Jee, Richard T Lostritto

Clin Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA drug approval summaries: fulvestrant.
Peter F Bross, Martin H Cohen, Grant A Williams, Richard Pazdur

Oncologist· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis